-
Mashup Score: 3
William Blair analysts called the clearance a positive surprise, explaining that the FDA has denied several therapies in the patient population.
Source: www.medtechdive.comCategories: General Medicine News, General HCPsTweet
William Blair analysts called the clearance a positive surprise, explaining that the FDA has denied several therapies in the patient population.
.@Neuronetics wins #FDA clearance for transcranial magnetic stimulation #TMS device to treat adolescents with #depression | #mentalhealth https://t.co/msc2nm5Imh